Chris Bond

Company: Notch Therapeutics

Job title: Senior Vice President Preclinical & Translational Sciences

Seminars:

Engineered iPS Derived T-Cells for Solid & Hematological Tumours 12:30 pm

Engineered iPS derived cell therapies can be designed to overcome multiple mechanisms of treatment failure and relapse PSC derived therapies provide a homogenous and uniform source of off-the-shelf cell therapy productsRead more